Ransom Advisory’s GSK GSK Stock Holding History

Ransom Advisory’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$219K	Buy	4,475 +582	+15%	+$27.1K	0.09%	123
2025 Q3	$168K	Hold	3,893	–	–	0.08%	115
2025 Q2	$149K	Hold	3,893	–	–	0.07%	116
2025 Q1	$151K	Hold	3,893	–	–	0.07%	122
2024 Q4	$132K	Hold	3,893	–	–	0.06%	141
2024 Q3	$159K	Hold	3,893	–	–	0.07%	134
2024 Q2	$150K	Hold	3,893	–	–	0.08%	135
2024 Q1	$167K	Buy	+3,893	New	+$161K	0.09%	123

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ransom Advisory's GSK Position: Q4 2025 in Review

Ransom Advisory increased its GSK (GSK) stake by 15% in Q4 2025, buying an estimated $27.1K and bringing the position to 4,475 shares worth $219K. The position accounts for 0.09% of the portfolio, ranked #123.

Ransom Advisory first reported a position in GSK in Q1 2024 and has held it in 8 quarters since. 996 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

Ransom Advisory held 4,475 shares of GSK worth $219K as of Q4 2025.
Ransom Advisory bought 582 GSK shares in Q4 2025, an estimated $27.1K.
GSK made up 0.09% of Ransom Advisory's portfolio in Q4 2025, its #123 holding.
Ransom Advisory first reported a position in GSK in Q1 2024 and has held it in 8 quarters since.
996 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on Ransom Advisory's 13F filing for Q4 2025, filed 6 Jan 2026.